Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Plant-derived cyclopamine vies as possible BCC treatment
Dallas - The efficacy of cyclopamine as a mechanism-based treatmentfor basal cell carcinoma is a research area that dermatologists should expectto hear more about in the future, said Stanley J. Miller, M.D., at the annualjoint meeting of the American Society for Dermatologic Surgery and the AmericanCollege of Mohs Micrographic Surgery and Cutaneous Oncology.
Recent Videos
Related Content
